Moreover, neurotrophin signaling pathway was the most highly enriched pathway associated with AML drug resistance with the five deregulated mediators including the upregulation of SORT1 and AKT3 genes, and the downregulation of c-Jun, MATK, and RPS6KA2 genes. The gene discussed is AKT3; the disease is acute myeloid leukemia.